A phase 1 dose escalation study of protein arginine methyltransferase 5 (PRMT5) inhibitor PRT543 in patients with myeloid malignancies Meeting Abstract
| Authors: | Patel, M. R.; Monga, V.; Jauhari, S.; Stevens, D.; Masarova, L.; McKean, M.; Mauro, D.; Viscusi, J.; Scherle, P.; Bhagwat, N.; Moore, A.; Sun, W.; Chiaverelli, R.; Mintah, E.; Nath, R.; Stein, E. M.; Palmisiano, N.; Sutamtewagul, G.; Verstovsek, S. |
| Abstract Title: | A phase 1 dose escalation study of protein arginine methyltransferase 5 (PRMT5) inhibitor PRT543 in patients with myeloid malignancies |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736413902123 |
| DOI: | 10.1182/blood-2021-150938 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2609 -- Hybrid meeting, also took place online -- Source: Wos |
